SecSonar.com

Clene Inc. (CLNN)

Clene Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Clene Inc. (CLNN) is a Biotechnology company based in US with a market capitalization of $67.7M. Revenue declined 41.5% year-over-year and free cash flow was negative at -$18.6M. This page tracks CLNN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 75 employees · IPO Oct 18, 2018

Valuation

Valuation & price

$7.14 · as of May 17, 2026 · -42.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$12.50$7.93$3.36Jul 25Dec 25Jul 26Jul 7, 25$3.87Jul 9, 25$3.83Jul 11, 25$3.59Jul 15, 25$3.70Jul 17, 25$3.90Jul 21, 25$3.87Jul 23, 25$3.74Jul 25, 25$3.65Jul 29, 25$3.36Jul 31, 25$3.54Aug 4, 25$3.74Aug 6, 25$3.66Aug 11, 25$3.82Aug 13, 25$3.65Aug 15, 25$3.62Aug 19, 25$4.48Aug 21, 25$5.34Aug 25, 25$5.33Aug 27, 25$5.38Aug 29, 25$5.32Sep 3, 25$5.59Sep 5, 25$6.03Sep 9, 25$6.60Sep 11, 25$6.18Sep 16, 25$6.33Sep 18, 25$6.32Sep 22, 25$6.40Sep 24, 25$6.05Sep 26, 25$5.88Sep 30, 25$6.03Oct 2, 25$8.01Oct 6, 25$10.36Oct 8, 25$9.42Oct 10, 25$8.60Oct 14, 25$8.59Oct 16, 25$8.25Oct 21, 25$8.62Oct 23, 25$8.15Oct 27, 25$8.51Oct 29, 25$9.14Oct 31, 25$12.50Nov 4, 25$10.92Nov 6, 25$9.25Nov 10, 25$10.09Nov 12, 25$9.41Nov 14, 25$8.52Nov 18, 25$8.56Nov 20, 25$8.76Nov 25, 25$9.45Nov 28, 25$10.36Dec 2, 25$9.26Dec 4, 25$6.29Dec 8, 25$5.86Dec 10, 25$6.68Dec 12, 25$6.77Dec 16, 25$6.43Dec 18, 25$6.04Dec 22, 25$6.44Dec 24, 25$6.36Dec 29, 25$5.89Jan 2, 26$5.77Jan 6, 26$6.14Jan 8, 26$5.97Jan 12, 26$5.18Jan 14, 26$5.12Jan 16, 26$5.05Jan 21, 26$5.19Jan 23, 26$5.31Jan 27, 26$5.19Jan 29, 26$4.17Feb 2, 26$4.04Feb 4, 26$3.99Feb 9, 26$4.45Feb 11, 26$4.13Feb 13, 26$4.23Feb 18, 26$4.52Feb 20, 26$4.64Feb 24, 26$5.04Feb 26, 26$5.36Mar 2, 26$5.24Mar 4, 26$5.51Mar 6, 26$5.36Mar 10, 26$5.44Mar 12, 26$5.92Mar 17, 26$6.13Mar 19, 26$5.87Mar 23, 26$5.67Mar 25, 26$5.48Mar 27, 26$4.71Mar 31, 26$4.93Apr 2, 26$5.12Apr 7, 26$6.26Apr 9, 26$6.34Apr 13, 26$6.48Apr 15, 26$6.35Apr 17, 26$6.31Apr 22, 26$6.57Apr 24, 26$5.91Apr 28, 26$5.85Apr 30, 26$6.16May 4, 26$8.09May 6, 26$7.16May 8, 26$7.28May 12, 26$6.50May 14, 26$7.05May 18, 26$6.79May 20, 26$6.90May 22, 26$6.70May 28, 26$6.70Jun 1, 26$6.11Jun 3, 26$5.76Jun 5, 26$5.45Jun 9, 26$5.57Jun 11, 26$5.53Jun 15, 26$5.77Jun 17, 26$5.93Jun 22, 26$5.89Jun 24, 26$5.74Jun 26, 26$6.06Jul 2, 26$6.10
$3.3652-week range$12.50
Loading valuation history…

Fundamentals

Key fundamentals

$67.7M

Market cap

-41.5%

Revenue growth (YoY)

78.5%

Gross margin

-$18.6M

Free cash flow (USD)

$16.5M

Net debt

41.8%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$206.0KFY 2021$723.0KFY 2022$473.0KFY 2023$654.0KFY 2024$342.0KFY 2025$200.0K
$0$200K

Free cash flow by year

2018 → 2025

FY 2018$-957.4KFY 2019$-13.5MFY 2020$-19.3MFY 2021$-36.0MFY 2022$-44.2MFY 2023$-30.5MFY 2024$-21.3MFY 2025$-18.6M
-$957.4K-$18.6M

Gross margin by year

2021 → 2025

FY 202160.0%FY 202294.5%FY 202381.5%FY 202479.5%FY 202578.5%
60.0%78.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

6

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-0.31)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventStock Plan AmendmentMay 22, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Insider sellInsider Sell $604KUgwumba Chidozie · 10% Owner · $604.1KMay 13, 2026Filing
  • Insider sellInsider Sell $530KUgwumba Chidozie · 10% Owner · $530.4KMay 5, 2026Filing
  • 8-K eventCommon Stock OfferingMay 5, 2026Filing
  • 8-K eventNDA Filing AnnouncementMay 4, 2026Filing
  • Insider sellInsider Sell $113KUgwumba Chidozie · 10% Owner · $112.8KApr 30, 2026Filing
  • Insider sellInsider Sell $403KUgwumba Chidozie · 10% Owner · $403.1KApr 22, 2026Filing
  • Insider sellInsider Sell $252KUgwumba Chidozie · 10% Owner · $251.9KApr 17, 2026Filing

Questions

Frequently asked questions

What is Clene Inc.'s market cap?

Clene Inc. (CLNN) has a market capitalization of $67.7M.

What is CLNN's P/E ratio?

A meaningful P/E ratio is not available for CLNN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did Clene Inc. last report earnings?

CLNN last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying CLNN stock?

SEC Form 4 filings show no open-market insider buys at Clene Inc. in the last 90 days (6 sells).

Same arena

Related companies in Biotechnology

TCRX

TScan Therapeutics, Inc.

$67.2M

SPRB

Spruce Biosciences, Inc.

$68.2M

CBUS

Cibus, Inc.

$66.6M

MNOV

MediciNova, Inc.

$66M

IMA

ImageneBio Inc

$65.9M

IMMP

Immutep Limited

$65M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.